Skip to main content
Clinical Trials/IRCT138901213678N1
IRCT138901213678N1
Completed
Phase 2

A double blind clinical trial for study of preventive effect of selenium in cisplatin induced nephrotoxicity

Research deputy of Ahvaz Jundishapur university of medical sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Acute renal failure due to Cisplatin.
Sponsor
Research deputy of Ahvaz Jundishapur university of medical sciences
Enrollment
80
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Research deputy of Ahvaz Jundishapur university of medical sciences

Eligibility Criteria

Inclusion Criteria

  • Patients who were referred to Shafa hospital for chemotherapy with Cisplatin1388\-1389
  • Exclusion criteria:1\) serum Creatinine more than 1\.5mg/dl in man and more than 1\.4mg/dl
  • 2\) Use of other nephrotoxic drug such as NSAID, ACEI, Aminoglycoside
  • at 2 weeks later
  • 4\) Pancytopenia
  • 5\) Patient who refused Selenium

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials